A $1.6 million research effort is set to advance single-molecule proteomics research in Parkinson’s disease (PD). Life sciences company Nautilus Biotechnology has partnered with Weill Cornell Medicine-Qatar (WCM-Q) and The Michael J Fox Foundation (MJFF) to study the connection between the alpha-synuclein (aSyn) protein and PD. The project will combine WCM-Q’s lab expertise in the molecular and chemical biology […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!